{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:33:12Z","timestamp":1786116792156,"version":"build-2736575974"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004431","name":"Fondation de France","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004431","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003762","name":"Institut Pasteur","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003762","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Western Pacific"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.lanwpc.2026.101913","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T05:39:33Z","timestamp":1783057173000},"page":"101913","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Emergence of antimicrobial resistance in New Caledonia: 20-year trends from laboratory-based surveillance (2005\u20132024)"],"prefix":"10.1016","volume":"72","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-9228-4084","authenticated-orcid":false,"given":"Andrea","family":"Antoniolli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffany","family":"Ruge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Biron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praveen","family":"Rahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claude","family":"Flamand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2914-7597","authenticated-orcid":false,"given":"Alexandre","family":"Bourles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0690-9464","authenticated-orcid":false,"given":"Cyrille","family":"Goarant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Colot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lanwpc.2026.101913_bib1","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0140-6736(24)01867-1","article-title":"Global burden of bacterial antimicrobial resistance 1990\u20132021: a systematic analysis with forecasts to 2050","volume":"404","author":"Naghavi","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.lanwpc.2026.101913_bib2","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S1473-3099(25)00118-5","article-title":"The WHO Bacterial Priority Pathogens List 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial resistance","volume":"25","author":"Sati","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.lanwpc.2026.101913_bib3","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0140-6736(15)00473-0","article-title":"Understanding the mechanisms and drivers of antimicrobial resistance","volume":"387","author":"Holmes","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.lanwpc.2026.101913_bib4","series-title":"Global antibiotic resistance surveillance report 2025: WHO Global Antimicrobial Resistance and Use Surveillance System (GLASS)","year":"2025"},{"key":"10.1016\/j.lanwpc.2026.101913_bib5","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/j.1469-0691.2008.02068.x","article-title":"Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii in New Caledonia","volume":"14","author":"Le Hello","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.lanwpc.2026.101913_bib6","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.jgar.2022.07.005","article-title":"A fusidic acid-resistant (PVL+) clone is associated with the increase in methicillin-resistant Staphylococcus aureus in New Caledonia","volume":"30","author":"Bourles","year":"2022","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.lanwpc.2026.101913_bib7","article-title":"Community-acquired Panton-Valentine Leukocidin producing Staphylococcus aureus infections in adult ICU patients in New Caledonia Island: a cohort study","volume":"41","author":"Imauven","year":"2022","journal-title":"Anaesth Crit Care Pain Med"},{"key":"10.1016\/j.lanwpc.2026.101913_bib8","doi-asserted-by":"crossref","first-page":"2","DOI":"10.33321\/cdi.2011.35.1","article-title":"Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific and South East Asian Regions, 2009","volume":"35","year":"2011","journal-title":"Commun Dis Intell Q Rep"},{"key":"10.1016\/j.lanwpc.2026.101913_bib9","first-page":"946","article-title":"MCR-1 in ESBL-producing Escherichia coli responsible for human infections in New Caledonia","volume":"72","author":"Robin","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.lanwpc.2026.101913_bib10","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.idnow.2021.08.005","article-title":"Prevention and control of highly antibiotic-resistant bacteria in a Pacific territory: feedback from New Caledonia between 2004 and 2020","volume":"52","author":"Colot","year":"2022","journal-title":"Infect Dis Now"},{"key":"10.1016\/j.lanwpc.2026.101913_bib11","series-title":"Decade of carbapenemase-producing Enterobacterales in New Caledonia: integrative surveillance though genomic, phenotypic and clinical approaches","author":"Colot","year":"2024"},{"key":"10.1016\/j.lanwpc.2026.101913_bib12","doi-asserted-by":"crossref","DOI":"10.1128\/jcm.00276-21","article-title":"Update from the European Committee on Antimicrobial Susceptibility Testing (EUCAST)","volume":"60","author":"Giske","year":"2022","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.lanwpc.2026.101913_bib13","first-page":"61","article-title":"Surveillance de la consommation des antibiotiques et des r\u00e9sistances bact\u00e9riennes en \u00e9tablissement de sant\u00e9: mission SPARES. R\u00e9sultats 2023","volume":"358","year":"2024","journal-title":"Rev Biol M\u00e9d"},{"key":"10.1016\/j.lanwpc.2026.101913_bib14","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3390\/medicina56100507","article-title":"Importance of susceptibility rate of \u2018the First\u2019 isolate: evidence of real-world data","volume":"56","author":"Kim","year":"2020","journal-title":"Medicina (Mex)"},{"key":"10.1016\/j.lanwpc.2026.101913_bib15","first-page":"14","article-title":"Nosocomial infections","volume":"5","author":"Inweregbu","year":"2005","journal-title":"Cont Educ Anaesth Crit Care Pain"},{"key":"10.1016\/j.lanwpc.2026.101913_bib16","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.lanwpc.2026.101913_bib17","series-title":"The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters","year":"2025"},{"key":"10.1016\/j.lanwpc.2026.101913_bib18","series-title":"The European Committee on antimicrobial susceptibility testing. Expected resistant phenotypes","year":"2022"},{"key":"10.1016\/j.lanwpc.2026.101913_bib19","series-title":"The European Committee on antimicrobial susceptibility testing. Guidance document on Stenotrophomonas maltophilia","year":"2024"},{"key":"10.1016\/j.lanwpc.2026.101913_bib21","article-title":"Australian gonococcal surveillance programme annual report, 2022","volume":"47","author":"Lahra","year":"2023","journal-title":"Commun Dis Intell"},{"key":"10.1016\/j.lanwpc.2026.101913_bib22","doi-asserted-by":"crossref","first-page":"4826","DOI":"10.1128\/JCM.43.9.4826-4829.2005","article-title":"Outbreak of carbapenem-resistant Acinetobacter baumannii producing the carbapenemase OXA-23 in a tertiary care Hospital of papeete, French Polynesia","volume":"43","author":"Naas","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.lanwpc.2026.101913_bib23","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1071\/MA21031","article-title":"Escherichia coli: placing resistance to third-generation cephalosporins and fluoroquinolones in Australia and New Zealand into perspective","volume":"42","author":"White","year":"2021","journal-title":"Microbiol Aust"},{"key":"10.1016\/j.lanwpc.2026.101913_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2022.106535","article-title":"Prevalence of ESBL non-CRE Escherichia coli and Klebsiella pneumoniae among clinical isolates collected by the SMART global surveillance programme from 2015 to 2019","volume":"59","author":"Karlowsky","year":"2022","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.lanwpc.2026.101913_bib25","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3390\/antibiotics9040151","article-title":"Bacteriology and Antimicrobial Resistance in Vanuatu: January 2017 to December 2019","volume":"9","author":"Foxlee","year":"2020","journal-title":"Antibiotics"},{"key":"10.1016\/j.lanwpc.2026.101913_bib26","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s13756-018-0412-3","article-title":"Factors associated with bacteraemia due to multidrug-resistant organisms among bacteraemic patients with multidrug-resistant organism carriage: a case control study","volume":"7","author":"Mascitti","year":"2018","journal-title":"Antimicrob Resist Infect Control"},{"key":"10.1016\/j.lanwpc.2026.101913_bib27","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3390\/antibiotics8010029","article-title":"Antibiotic resistance in Pacific Island countries and territories: a systematic scoping review","volume":"8","author":"Foxlee","year":"2019","journal-title":"Antibiotics"},{"key":"10.1016\/j.lanwpc.2026.101913_bib28","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1093\/jac\/dkad127","article-title":"Incidence of ESBLs and carbapenemases among Enterobacterales and carbapenemases in Pseudomonas aeruginosa isolates collected globally: results from ATLAS 2017-2019","volume":"78","author":"Gales","year":"2023","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.lanwpc.2026.101913_bib29","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ijid.2015.10.013","article-title":"Bacteremic community-acquired infections due to Klebsiella pneumoniae: clinical and microbiological presentation in New Caledonia, 2008\u20132013","volume":"41","author":"Melot","year":"2015","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.lanwpc.2026.101913_bib30","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.3390\/antibiotics10091140","article-title":"Detection of multidrug-resistant Enterobacterales\u2014From ESBLs to Carbapenemases","volume":"10","author":"Noster","year":"2021","journal-title":"Antibiotics"},{"key":"10.1016\/j.lanwpc.2026.101913_bib31","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1038\/s41467-025-58597-6","article-title":"Ceftazidime-avibactam use selects multidrug-resistance and prevents designing collateral sensitivity-based therapies against Pseudomonas aeruginosa","volume":"16","author":"Hernando-Amado","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.lanwpc.2026.101913_bib32","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/j.1469-0691.2006.01456.x","article-title":"Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology","volume":"12","author":"Poirel","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.lanwpc.2026.101913_bib33","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1586\/14787210.2014.956092","article-title":"Mechanisms of antibiotic resistance in enterococci","volume":"12","author":"Miller","year":"2014","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.lanwpc.2026.101913_bib34","doi-asserted-by":"crossref","DOI":"10.1093\/jacamr\/dlae053","article-title":"High prevalence of ceftriaxone-resistant and XDR Neisseria gonorrhoeae in several cities of Cambodia, 2022-23: WHO Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP)","volume":"6","author":"Ouk","year":"2024","journal-title":"JAC Antimicrob Resist"},{"key":"10.1016\/j.lanwpc.2026.101913_bib35","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.18082","article-title":"Epidemiology and burden of multidrug-resistant bacterial infection in a developing country","volume":"5","author":"Lim","year":"2016","journal-title":"eLife"},{"key":"10.1016\/j.lanwpc.2026.101913_bib36","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s00134-022-06944-2","article-title":"Epidemiology and outcomes of hospital-acquired bloodstream infections in intensive care unit patients: the EUROBACT-2 international cohort study","volume":"49","author":"Tabah","year":"2023","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.lanwpc.2026.101913_bib37","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.53886","article-title":"Systematic detection of horizontal gene transfer across genera among multidrug-resistant bacteria in a single hospital","volume":"9","author":"Evans","year":"2020","journal-title":"eLife"},{"key":"10.1016\/j.lanwpc.2026.101913_bib38","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/s44259-025-00137-9","article-title":"The hospital sink drain microbiome as a melting pot for AMR transmission to nosocomial pathogens","volume":"3","author":"McCallum","year":"2025","journal-title":"Npj Antimicrob Resist"},{"key":"10.1016\/j.lanwpc.2026.101913_bib39","doi-asserted-by":"crossref","DOI":"10.1093\/jacamr\/dlac036","article-title":"Risk factors for carriage of antimicrobial-resistant bacteria in community dwelling-children in the Asia-Pacific region: a systematic review and meta-analysis","volume":"4","author":"Chan","year":"2022","journal-title":"JAC Antimicrob Resist"},{"key":"10.1016\/j.lanwpc.2026.101913_bib40","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3390\/diseases13060179","article-title":"Sex differences in immune responses to infectious diseases: the role of genetics, hormones, and aging","volume":"13","author":"Rio","year":"2025","journal-title":"Diseases"},{"key":"10.1016\/j.lanwpc.2026.101913_bib41","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1093\/cid\/civ576","article-title":"Gender differences in rates of carriage and bloodstream infection caused by methicillin-resistant staphylococcus aureus: are they real, do they matter and why?","volume":"61","author":"Humphreys","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lanwpc.2026.101913_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0228234","article-title":"Comparison of de-duplication methods used by WHO Global Antimicrobial Resistance Surveillance System (GLASS) and Japan Nosocomial Infections Surveillance (JANIS) in the surveillance of antimicrobial resistance","volume":"15","author":"Kajihara","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.lanwpc.2026.101913_bib43","article-title":"Modifiable Temporal Unit Problem (MTUP) and its effect on space-time cluster detection","volume":"9","author":"Cheng","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.lanwpc.2026.101913_bib44","series-title":"Comit\u00e9 de l\u2019antibiogramme Recommandation 2011","year":"2011"},{"key":"10.1016\/j.lanwpc.2026.101913_bib45","series-title":"Like: Comit\u00e9 de l\u2019antibiogramme de la Soci\u00e9t\u00e9 Fran\u00e7aise de Microbiologie. Recommandations 2008","year":"2008"},{"key":"10.1016\/j.lanwpc.2026.101913_bib46","series-title":"A Comparison of MICs Determined by the CDS, CLSI and EUCAST Reference Techniques","author":"Allerton","year":"2017"},{"key":"10.1016\/j.lanwpc.2026.101913_bib47","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.cmi.2019.03.016","article-title":"Time to switch from CLSI to EUCAST? A Southeast Asian perspective","volume":"25","author":"Cusack","year":"2019","journal-title":"Clin Microbiol Infect"}],"container-title":["The Lancet Regional Health - Western Pacific"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666606526001173?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666606526001173?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T12:33:00Z","timestamp":1786019580000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666606526001173"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":46,"alternative-id":["S2666606526001173"],"URL":"https:\/\/doi.org\/10.1016\/j.lanwpc.2026.101913","relation":{},"ISSN":["2666-6065"],"issn-type":[{"value":"2666-6065","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emergence of antimicrobial resistance in New Caledonia: 20-year trends from laboratory-based surveillance (2005\u20132024)","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Western Pacific","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanwpc.2026.101913","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101913"}}